CCL5 neutralization restricts cancer growth and potentiates the targeting of PDGFRβ in colorectal carcinoma.
Increased CCL5 levels are markers of an unfavourable outcome in patients with melanoma, breast, cervical, prostate, gastric or pancreatic cancer. Here, we have assessed the role played by CCL5/CCR5 interactions in the development of colon cancer. To do so, we have examined a number of human colorect...
Guardado en:
Autores principales: | Béatrice Cambien, Peggy Richard-Fiardo, Babou F Karimdjee, Violette Martini, Bernard Ferrua, Bruno Pitard, Heidy Schmid-Antomarchi, Annie Schmid-Alliana |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/331ae96239844c2e8fef57a3574437c4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2
por: Simone Romagnoli, et al.
Publicado: (2021) -
Laminin regulates PDGFRβ+ cell stemness and muscle development
por: Yao Yao, et al.
Publicado: (2016) -
CHEMOKINES CCL17 AND CCL22 IN SARCOIDOSIS
por: N. M. Lazareva, et al.
Publicado: (2021) -
Contribution of PDGFRα-positive cells in maintenance and injury responses in mouse large vessels
por: Kenichi Kimura, et al.
Publicado: (2021) -
Identification of PDGFRα-positive interstitial cells in the distal segment of the murine vas deferens
por: Tasuku Hiroshige, et al.
Publicado: (2021)